FIVE YEAR ANNIVERSARY
Pearl River Laboratories Inc has been successful from the start.
Our partnership with customers is built on a foundation of exceptional science, unwavering quality, customer-focused service and timely delivery.
2019 to 2025
https://www.pearlriverlabs.com
Pearl River Labs Achieves Key Milestones in Bioconjugation and Analytical Excellence in 2024
Pearl River Labs has marked a year of significant achievements in advancing bioconjugation science and analytical development. The company delivered innovative solutions across multiple fronts, including:
• Antibody-Oligonucleotide Conjugates (AOCs): Comprehensive preparation of AOCs from discovery through regulatory toxicology, alongside the development and qualification of robust companion analytical methods.
• Protein-Polysaccharide Conjugates: Successful preparation of complex conjugates and development of cutting-edge analytical techniques to support them.
• Site-Specific & Conventional ADC Conjugation: Expertise in site-specific & conventional conjugation of antibody-drug conjugates (ADCs) and their in-depth characterization.
• Method Development and Validation for Late-Stage Assets: Advanced method development and validation to support the late-stage pipeline.
• Formulation Development and Stability Studies: Formulation development and stability studies for early and late stage candidates.
• Reference Standard Preparation: Delivering high-quality reference standards to meet industry and regulatory needs.
These accomplishments underscore Pearl River Labs’ commitment to excellence in bioconjugation, method development & validation, regulatory compliance, and delivering solutions that drive biopharmaceutical innovation.